FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2975769673> ?p ?o ?g. }

• W2975769673 endingPage "677" @default.
• W2975769673 startingPage "672" @default.
• W2975769673 abstract "Background This study aimed to elucidate visual benefits of ranibizumab in patients with neovascular age-related macular degeneration (nAMD) compared with control arms and identify factors affecting response. Methods This is a post-hoc pooled analysis of two phase III studies, ANCHOR and MARINA, of ranibizumab for the treatment of nAMD. ANCHOR included 83 international sites. MARINA included 96 sites in the USA. Analysis included patients (control, n=323; ranibizumab, n=332) with nAMD and a baseline best-corrected visual acuity (BCVA) of ≥35–<85 letters. Results Patients receiving ranibizumab achieved an adjusted mean BCVA superiority of 18.9 and 21.2 letters over 12 and 24 months, respectively, compared with control. Ranibizumab treatment, higher baseline BCVA, lower age and smaller lesion size were positively associated with the ability to achieve BCVA >69 letters. Patients with the highest baseline BCVA had lowest BCVA gains. Ranibizumab treatment, lower baseline BCVA, lower age and smaller lesion size were identified as significant predictors of BCVA gain from baseline at month 24 (all p<0.0001). However, the difference in mean BCVA gains at month 24 between treatment and control groups was similar for all baseline BCVA subgroups (≥35–<55 letters, 21.9 letters; ≥55–<70 letters, 25.2 letters; ≥70–<85 letters, 19.3 letters). Conclusions Higher baseline BCVA is associated with lower BCVA gains but a greater likelihood of achieving good final BCVA >69 letters due to smaller gains needed to achieve response. Visual benefits, including maintenance of visual acuity (VA), final VA achieved and relative gain compared with natural disease progression, should be considered when assessing treatment response in nAMD." @default.
• W2975769673 created "2019-10-03" @default.
• W2975769673 creator A5016588157 @default.
• W2975769673 creator A5033702319 @default.
• W2975769673 creator A5055312302 @default.
• W2975769673 creator A5090676211 @default.
• W2975769673 date "2019-09-27" @default.
• W2975769673 modified "2023-09-25" @default.
• W2975769673 title "Visual benefit versus visual gain: what is the effect of baseline covariants in the treatment arm relative to the control arm? A pooled analysis of ANCHOR and MARINA" @default.
• W2975769673 cites W1481978003 @default.
• W2975769673 cites W1493343577 @default.
• W2975769673 cites W1500728559 @default.
• W2975769673 cites W1544345685 @default.
• W2975769673 cites W1594542483 @default.
• W2975769673 cites W1965184678 @default.
• W2975769673 cites W1970742275 @default.
• W2975769673 cites W1996171994 @default.
• W2975769673 cites W2003324689 @default.
• W2975769673 cites W2004361001 @default.
• W2975769673 cites W2008455201 @default.
• W2975769673 cites W2009150210 @default.
• W2975769673 cites W2011187017 @default.
• W2975769673 cites W2011393181 @default.
• W2975769673 cites W2026412769 @default.
• W2975769673 cites W2032203134 @default.
• W2975769673 cites W2034477424 @default.
• W2975769673 cites W2042321005 @default.
• W2975769673 cites W2063620836 @default.
• W2975769673 cites W2068742492 @default.
• W2975769673 cites W2073559780 @default.
• W2975769673 cites W2075984382 @default.
• W2975769673 cites W2080886828 @default.
• W2975769673 cites W2085712747 @default.
• W2975769673 cites W2091636586 @default.
• W2975769673 cites W2112641578 @default.
• W2975769673 cites W2123232376 @default.
• W2975769673 cites W2124415048 @default.
• W2975769673 cites W2134161293 @default.
• W2975769673 cites W2160726762 @default.
• W2975769673 cites W2161279821 @default.
• W2975769673 cites W2165794331 @default.
• W2975769673 cites W2172453889 @default.
• W2975769673 cites W2753708825 @default.
• W2975769673 cites W2766004112 @default.
• W2975769673 cites W2789226077 @default.
• W2975769673 cites W2915852396 @default.
• W2975769673 doi "https://doi.org/10.1136/bjophthalmol-2018-313682" @default.
• W2975769673 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7212932" @default.
• W2975769673 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31562118" @default.
• W2975769673 hasPublicationYear "2019" @default.
• W2975769673 type Work @default.
• W2975769673 sameAs 2975769673 @default.
• W2975769673 citedByCount "13" @default.
• W2975769673 countsByYear W29757696732020 @default.
• W2975769673 countsByYear W29757696732021 @default.
• W2975769673 countsByYear W29757696732022 @default.
• W2975769673 countsByYear W29757696732023 @default.
• W2975769673 crossrefType "journal-article" @default.
• W2975769673 hasAuthorship W2975769673A5016588157 @default.
• W2975769673 hasAuthorship W2975769673A5033702319 @default.
• W2975769673 hasAuthorship W2975769673A5055312302 @default.
• W2975769673 hasAuthorship W2975769673A5090676211 @default.
• W2975769673 hasBestOaLocation W29757696731 @default.
• W2975769673 hasConcept C111368507 @default.
• W2975769673 hasConcept C118487528 @default.
• W2975769673 hasConcept C119767625 @default.
• W2975769673 hasConcept C126322002 @default.
• W2975769673 hasConcept C12725497 @default.
• W2975769673 hasConcept C127313418 @default.
• W2975769673 hasConcept C141071460 @default.
• W2975769673 hasConcept C2776403814 @default.
• W2975769673 hasConcept C2776694085 @default.
• W2975769673 hasConcept C2777802072 @default.
• W2975769673 hasConcept C2778257484 @default.
• W2975769673 hasConcept C2781100027 @default.
• W2975769673 hasConcept C2992886853 @default.
• W2975769673 hasConcept C67761136 @default.
• W2975769673 hasConcept C71924100 @default.
• W2975769673 hasConceptScore W2975769673C111368507 @default.
• W2975769673 hasConceptScore W2975769673C118487528 @default.
• W2975769673 hasConceptScore W2975769673C119767625 @default.
• W2975769673 hasConceptScore W2975769673C126322002 @default.
• W2975769673 hasConceptScore W2975769673C12725497 @default.
• W2975769673 hasConceptScore W2975769673C127313418 @default.
• W2975769673 hasConceptScore W2975769673C141071460 @default.
• W2975769673 hasConceptScore W2975769673C2776403814 @default.
• W2975769673 hasConceptScore W2975769673C2776694085 @default.
• W2975769673 hasConceptScore W2975769673C2777802072 @default.
• W2975769673 hasConceptScore W2975769673C2778257484 @default.
• W2975769673 hasConceptScore W2975769673C2781100027 @default.
• W2975769673 hasConceptScore W2975769673C2992886853 @default.
• W2975769673 hasConceptScore W2975769673C67761136 @default.
• W2975769673 hasConceptScore W2975769673C71924100 @default.
• W2975769673 hasIssue "5" @default.
• W2975769673 hasLocation W29757696731 @default.
• W2975769673 hasLocation W29757696732 @default.
• W2975769673 hasLocation W29757696733 @default.
• W2975769673 hasLocation W29757696734 @default.

• next